Sunday, September 20, 2026

CBOE Bearish By 10% In The Last 21 Sessions

CBOE Bearish By 10% In The Last 21 Sessions

(VIANEWS) - CBOE (VIX) has been up by 10.35% for the last 21 sessions. At 05:08 EST on Wednesday, 29 May, CBOE (VIX) is $14.03.

Concerning CBOE's yearly highs and lows, it's 2.26% up from its 52-week low and 59.97% down from its 52-week high.

Volatility

CBOE's last week, last month's, and last quarter's current intraday variation average was a positive 2.19%, a negative 0.46%, and a positive 4.08%, respectively.

CBOE's highest amplitude of average volatility was 5.71% (last week), 4.05% (last month), and 4.08% (last quarter), respectively.

Index Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CBOE's is considered to be oversold (<=20).

News about

  • According to FXStreet on Tuesday, 28 May, "This morning, the S&P 500 index is likely to open 0.1% higher, as indicated by futures contracts after the long holiday weekend in the U.S. The market may see some more uncertainty as investors await the important CB Consumer Confidence release at 10:00 a.m.", "Stock prices are likely to open slightly higher today, and the S&P 500 may extend its consolidation around the 5,300 level. "
  • According to FXStreet on Tuesday, 28 May, "After an extended weekend due to holiday on Monday on account of Memorial Day, the S&P 500 is expected to open on a cautiously bullish note. "
  • According to FXStreet on Wednesday, 29 May, "The immediate downside target for the S&P 500 upon confirmation of the reversal signal."

More news about CBOE (VIX).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com